Ultrasound monitoring of hepatic metastases during chemotherapy.
Grey-scale ultrasonography has been found to be the most sensitive method of detecting metastatic disease of the liver. In two cases the results of chemotherapy were monitored by ultrasound; the response to treatment could be distinguished from non-response and ultrasonography gave useful information when chemotherapy made radioisotope examination unreliable.
D000328:Adult; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010586:Phagocytes; D010808:Physical Examination; D011877:Radionuclide Imaging; D014463:Ultrasonography